Passport Capital’s Allergan plc AGN Stock Holding History

Passport Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-90,000	Closed	-$20.8M	–	196
2016 Q2	$20.8M	Buy	+90,000	New	+$20.8M	0.38%	53

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Passport Capital's AGN Position: Q4 2016 in Review

Passport Capital sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 375,134 shares — an estimated $86.4M sold.

Passport Capital first reported a position in AGN in Q2 2015 and held it in 3 quarters. The position peaked at $164M in Q2 2016. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

Passport Capital reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
Passport Capital sold 375,134 Allergan plc shares in Q4 2016, an estimated $86.4M.
Passport Capital first reported a position in Allergan plc in Q2 2015 and held it in 3 quarters.
Passport Capital's Allergan plc position peaked at $164M in Q2 2016.
1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Passport Capital's 13F filing for Q4 2016, filed 14 Feb 2017.